Sci2sci Raises €1.2M Pre-Seed to Make AI Trustworthy for Biopharma and Other Regulated Industries

sci2sci, a Berlin-based startup building a neurosymbolic memory layer for regulated industries, today announced it has raised €1.2 million in pre-seed funding. The round was co-led by Heliad and IBB Ventures, with participation from Robin Capital and Superangels. Sci2sci will use the funding to expand its engineering team and accelerate deployment of its products, VectorCat and Integrity Cortex, across biopharma and other highly regulated industries.

Read the full IBB Ventures press release here.